A carregar...

A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection

Background. DAS181, a novel host-directed antiviral in development for influenza treatment, was assessed in this phase II clinical trial. Methods. This study was a double-blind, placebo-controlled phase II clinical trial assessing influenza viral load and patient safety in otherwise healthy influenz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moss, Ronald B., Hansen, Carrie, Sanders, Rebecca L., Hawley, Stephen, Li, Tiejun, Steigbigel, Roy T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570175/
https://ncbi.nlm.nih.gov/pubmed/23045618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis622
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!